Mid-term follow-up after aortic valve replacement with the Carpentier Edwards Magna Ease prosthesis.

ABSTRACT:

Background

Approximately 250,000 heart valve operations are performed annually worldwide. An intensive research and development effort has led to progressively more advanced heart valve prostheses. The Carpentier-Edwards Perimount Magna Ease (CEPME) prosthesis represents the latest iteration of the Edwards Perimount series of aortic tissue valves. The current study aims to evaluate the midterm performance of this bioprosthesis.

Methods

Five hundred and eighteen patients with aortic stenosis underwent aortic valve replacement with the CEPME valve at Papworth Hospital between August 2008 and November 2011. After a minimum of 3 years from the index operation, eligible patients were retrospectively and consecutively recruited to participate. Recruitment was closed after 100 elig

SUBMITTER: Rajab TK 

PROVIDER: S-EPMC7397680 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature